Product Recalls in North Dakota

Product recalls affecting North Dakota — including food, drugs, consumer products, medical devices, and vehicles distributed to North Dakota. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 1,061 recalls have been distributed to North Dakota in the last 12 months.

47,938 total recalls
1,061 in last 12 months

Showing 9161–9180 of 47,938 recalls

DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Tropicamide Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Neomycin & Polymyxin B Sulfates Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Acetic Acid Otic Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Naloxone Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm went...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Hydromorphone Hydrochloride Injection Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Apotex Corp.

Recalled Item: Calcitonin Salmon (synthetic origin) Nasal Spray Recalled by Apotex Corp....

The Issue: Presence of Foreign Substance: Glass splinter particle entrapped inside the...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Gadget Island, Inc

Recalled Item: DYNAMITE SUPER capsule Recalled by Gadget Island, Inc Due to Undeclared...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 26, 2023· Gadget Island, Inc

Recalled Item: Pro Power Knight Plus capsule Recalled by Gadget Island, Inc Due to...

The Issue: Marketed without an Approved NDA/ANDA: FDA analysis found product to be...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lorazepam Injection Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: AK-POLY-BAC (bacitracin Zinc and Polymyxin B Sulfate) Ophthalmic Ointment...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Atropine Sulfate Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ropivacaine Hydrochloride Injection USP Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ephedrine Sulfate Injection Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Rifampin Capsules USP Recalled by Akorn, Inc. Due to CGMP Deviations: Firm...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Clobetasol Propionate Ointment Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Olopatadine HCl Ophthalmic Solution Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Artificial Tears Solution Recalled by Akorn, Inc. Due to CGMP Deviations:...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Ferrous Sulfate Iron Supplement Drops Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Megestrol Acetate Oral Suspension Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 26, 2023· Akorn, Inc.

Recalled Item: Lidocaine 2.5% & Prilocaine 2.5% Cream Recalled by Akorn, Inc. Due to CGMP...

The Issue: CGMP Deviations: Firm went out of business and could no longer continue...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund